These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1933580

  • 1. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA, Somers NM, Dunstan CR, Hills E, Evans M.
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA.
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [Abstract] [Full Text] [Related]

  • 3. Long-term experience with a calcium-thiazide treatment for Paget's disease of bone.
    Evans RA, Dunstan CR, Wong SY, Hills E.
    Miner Electrolyte Metab; 1982 Dec; 8(6):325-33. PubMed ID: 7167138
    [Abstract] [Full Text] [Related]

  • 4. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R, Bar-Shalom R.
    Harefuah; 1995 Mar 15; 128(6):358-62, 399. PubMed ID: 7750816
    [Abstract] [Full Text] [Related]

  • 5. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
    O'Donoghue DJ, Hosking DJ.
    Bone; 1987 Mar 15; 8(4):219-25. PubMed ID: 3128315
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
    González D, Vega E, Ghiringhelli G, Mautalen C.
    Calcif Tissue Int; 1987 Dec 15; 41(6):313-5. PubMed ID: 3124939
    [Abstract] [Full Text] [Related]

  • 7. [Salmon calcitonin nasal spray in the treatment of Paget's disease].
    Giustina A, Macca C, Bossoni S, Romanelli G, Zuccato F.
    Recenti Prog Med; 1989 Nov 15; 80(11):599-602. PubMed ID: 2623325
    [Abstract] [Full Text] [Related]

  • 8. Intranasal salmon calcitonin treatment of Paget's disease of bone. Results in nine patients.
    D'Agostino HR, Barnett CA, Zielinski XJ, Gordan GS.
    Clin Orthop Relat Res; 1988 May 15; (230):223-8. PubMed ID: 3365896
    [Abstract] [Full Text] [Related]

  • 9. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
    Reginster JY, Albert A, Franchimont P.
    Calcif Tissue Int; 1985 Dec 15; 37(6):577-80. PubMed ID: 3937575
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
    Gagel RF, Logan C, Mallette LE.
    J Am Geriatr Soc; 1988 Nov 15; 36(11):1010-4. PubMed ID: 3171038
    [Abstract] [Full Text] [Related]

  • 11. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
    Reginster JY, Jeugmans-Huynen AM, Albert A, Denis D, Franchimont P.
    J Bone Miner Res; 1988 Jun 15; 3(3):249-52. PubMed ID: 3213619
    [Abstract] [Full Text] [Related]

  • 12. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May 15; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 13. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A, Flores A, DeRose J, Wallach S.
    J Clin Endocrinol Metab; 1976 Mar 15; 42(3):459-63. PubMed ID: 1254686
    [Abstract] [Full Text] [Related]

  • 14. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY, Gennari C, Mautalen C, Deroisy R, Denis D, Lecart MP, Vandalem JL, Collette J, Franchimont P.
    Scand J Rheumatol; 1990 Mar 15; 19(1):83-6. PubMed ID: 2309107
    [No Abstract] [Full Text] [Related]

  • 15. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978 Mar 15; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 17. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F, Muff R, Dotti-Sigrist S, Dambacher MA, Fischer JA.
    J Clin Endocrinol Metab; 1988 Sep 05; 67(3):541-5. PubMed ID: 3410939
    [Abstract] [Full Text] [Related]

  • 18. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A, Baker RK, Wallach S.
    Metabolism; 1974 Nov 05; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Paget's disease of bone.
    Evans RA.
    Med J Aust; 1983 Feb 19; 1(4):159-62. PubMed ID: 6405139
    [Abstract] [Full Text] [Related]

  • 20. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD, Chapuy MC, Meunier PJ.
    Horm Metab Res; 1984 May 19; 16(5):258-61. PubMed ID: 6234216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.